EARLY DETECTION
There is significant risk in waiting to screen for colorectal cancer (CRC)1
As CRC metastasizes, the 5-year survival rate decreases1,2
![Image colorectal cancer diagram](/-/media/project/exactsciences/websites/cologuard-hcp/images/evolve-crc-approach/early-detection/5-year-survival-dt.jpg?h=521&iar=0&w=767&rev=07f4a2b5434241119bce300235bdfe06&hash=514B4A9E5C42CD1AD81858C3992D4F35)
5-year survival rates by stage of CRC1,2*:
Timely CRC screening and early detection are essential to help reduce mortality rates and potentially save lives3
Discover which patients are eligible for CRC screening with a noninvasive screening method
Despite the ACS lowering its initial screening age to 45 in 20185:
![Image 1 in 5 eligible patients](/-/media/project/exactsciences/websites/cologuard-hcp/images/evolve-crc-approach/early-detection/1-in-5-dt.jpg?h=630&iar=0&w=765&rev=5ecd506a919247e2900c07cd798f6b7a&hash=6D32EC9722012090051036D3110BA42A)
As of 2021, only 1 in 5 eligible patients aged 45 to 49 years reported screening for CRC6
Among eligible patients younger than 50 years, 52% were diagnosed with more advanced CRC vs 40% of patients over the age of 50 years.7‡- Based on people diagnosed with CRC in stage I, stage IIa, or stage IIb between 2013 and 2019.1
- Based on the percentage of cases diagnosed with CRC in stage II and stage III (38%) and in stage IV (22%).1
- Data from 2004-2015 from a retrospective study of National Cancer Database.7